We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
(+11%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$87.3M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$58.8M |
| 3 |
Wells Fargo
WFC
|
+$50M |
| 4 |
Archer Daniels Midland
ADM
|
+$46.7M |
| 5 |
Southern Company
SO
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$79.7M |
| 2 |
Cigna
CI
|
+$69.1M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$46.8M |
| 4 |
Caterpillar
CAT
|
+$42.7M |
| 5 |
DXC Technology
DXC
|
+$40M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.52% |
| 2 | Technology | 13.89% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 11.24% |
| 5 | Healthcare | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPRX
851
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.37M | 0.02% |
98,555
+59,255
| +151% | +$881K |
|
852
Pitney Bowes
PBI
$2.42B
| $1.37M | 0.02% |
193,161
+99,540
| +106% | +$804K |
|
|
ACHN
853
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.37M | 0.02% |
371,657
+148,972
| +67% | +$444K |
|
854
Factset
FDS
$9.05B
| $1.36M | 0.02% |
+6,100
| New | +$1.32M |
|
855
iShares Russell 2000 Value ETF
IWN
$14.4B
| $1.36M | 0.02% |
+10,253
| New | +$1.38M |
|
|
CATM
856
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $1.36M | 0.02% |
42,984
-35,642
| -45% | -$1.1M |
|
|
EVBG
857
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.36M | 0.02% |
23,565
+15,865
| +206% | +$856K |
|
858
Crown Castle
CCI
$32.7B
| $1.35M | 0.02% |
+12,170
| New | +$1.36M |
|
859
Lazard
LAZ
$4.37B
| $1.35M | 0.02% |
+28,100
| New | +$1.4M |
|
860
Eaton
ETN
$157B
| $1.35M | 0.02% |
15,571
-18,304
| -54% | -$1.5M |
|
861
National Beverage
FIZZ
$2.87B
| $1.35M | 0.02% |
23,120
+13,010
| +129% | +$730K |
|
862
LPL Financial
LPLA
$26.3B
| $1.35M | 0.02% |
20,900
-54,082
| -72% | -$3.59M |
|
863
NorthWestern Energy
NWE
$4.48B
| $1.33M | 0.02% |
22,643
-100
| -0.4% | -$5.93K |
|
|
BKI
864
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.32M | 0.02% |
25,501
-672
| -3% | -$36K |
|
|
XENT
865
DELISTED
Intersect ENT, Inc
XENT
| $1.32M | 0.02% |
46,041
+6,541
| +17% | +$196K |
|
|
I
866
DELISTED
INTELSAT S. A.
I
| $1.31M | 0.02% |
43,726
-42,874
| -50% | -$938K |
|
867
Pebblebrook Hotel Trust
PEB
$2.16B
| $1.31M | 0.02% |
36,046
-800
| -2% | -$30.5K |
|
868
Webster Financial
WBS
$12.3B
| $1.31M | 0.02% |
22,211
-1,195
| -5% | -$77.7K |
|
869
Dentsply Sirona
XRAY
$2.59B
| $1.31M | 0.02% |
+34,695
| New | +$1.44M |
|
|
REGI
870
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.31M | 0.02% |
45,350
+32,379
| +250% | +$718K |
|
871
Avient
AVNT
$3.45B
| $1.3M | 0.02% |
+29,798
| New | +$1.3M |
|
872
Fortinet
FTNT
$112B
| $1.3M | 0.02% |
70,610
+51,665
| +273% | +$790K |
|
873
Toro Company
TTC
$8.93B
| $1.3M | 0.02% |
+21,722
| New | +$1.32M |
|
874
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $1.3M | 0.02% |
+21,648
| New | +$1.37M |
|
875
Coca-Cola Europacific Partners
CCEP
$46.5B
| $1.3M | 0.02% |
+28,598
| New | +$1.22M |
|
Similar funds
Squarepoint's Q3 2018 Portfolio in Review
As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.
- Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
- Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
- Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
- Squarepoint opened 687 new positions and closed 456 in Q3 2018.
- Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.
Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.